These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Infectomics: genomics and proteomics of microbial infections. Huang SH; Triche T; Jong AY Funct Integr Genomics; 2002 Apr; 1(6):331-44. PubMed ID: 11957108 [TBL] [Abstract][Full Text] [Related]
26. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation. Xiao H; Suttapitugsakul S; Sun F; Wu R Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186 [TBL] [Abstract][Full Text] [Related]
27. Malaria proteomics: insights into the parasite-host interactions in the pathogenic space. Bautista JM; Marín-García P; Diez A; Azcárate IG; Puyet A J Proteomics; 2014 Jan; 97():107-25. PubMed ID: 24140976 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular proteomics: challenges and opportunities for cardiologists of the future]. Banfi C; Brioschi M; Tremoli E G Ital Cardiol (Rome); 2013; 14(7-8):495-503. PubMed ID: 23877547 [TBL] [Abstract][Full Text] [Related]
29. The role of mass spectrometry analysis in bacterial effector characterization. Scott NE; Hartland EL Biochem J; 2017 Aug; 474(16):2779-2784. PubMed ID: 28784697 [TBL] [Abstract][Full Text] [Related]
30. Proteomics in chromatin biology and epigenetics: Elucidation of post-translational modifications of histone proteins by mass spectrometry. Sidoli S; Cheng L; Jensen ON J Proteomics; 2012 Jun; 75(12):3419-33. PubMed ID: 22234360 [TBL] [Abstract][Full Text] [Related]
31. A proteomic view of the host-pathogen interaction: The host perspective. Hartlova A; Krocova Z; Cerveny L; Stulik J Proteomics; 2011 Aug; 11(15):3212-20. PubMed ID: 21726044 [TBL] [Abstract][Full Text] [Related]
32. A proteomic insight into the MSP1 and flg22 induced signaling in Oryza sativa leaves. Meng Q; Gupta R; Min CW; Kim J; Kramer K; Wang Y; Park SR; Finkemeier I; Kim ST J Proteomics; 2019 Mar; 196():120-130. PubMed ID: 29970347 [TBL] [Abstract][Full Text] [Related]
33. Characterizing disease-associated changes in post-translational modifications by mass spectrometry. Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447 [TBL] [Abstract][Full Text] [Related]
34. Quantitative proteomics of Sf21 cells during Baculovirus infection reveals progressive host proteome changes and its regulation by viral miRNA. Nayyar N; Kaur I; Malhotra P; Bhatnagar RK Sci Rep; 2017 Sep; 7(1):10902. PubMed ID: 28883418 [TBL] [Abstract][Full Text] [Related]
35. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Grassl N; Kulak NA; Pichler G; Geyer PE; Jung J; Schubert S; Sinitcyn P; Cox J; Mann M Genome Med; 2016 Apr; 8(1):44. PubMed ID: 27102203 [TBL] [Abstract][Full Text] [Related]
37. Mycobacteria and their sweet proteins: An overview of protein glycosylation and lipoglycosylation in M. tuberculosis. Mehaffy C; Belisle JT; Dobos KM Tuberculosis (Edinb); 2019 Mar; 115():1-13. PubMed ID: 30948163 [TBL] [Abstract][Full Text] [Related]
38. Mass Spectrometry-Based Bacterial Proteomics: Focus on Dermatologic Microbial Pathogens. Soufi Y; Soufi B Front Microbiol; 2016; 7():181. PubMed ID: 26925048 [TBL] [Abstract][Full Text] [Related]
39. Proteomic Approaches to Unravel Mechanisms of Antibiotic Resistance and Immune Evasion of Bacterial Pathogens. Torres-Sangiao E; Giddey AD; Leal Rodriguez C; Tang Z; Liu X; Soares NC Front Med (Lausanne); 2022; 9():850374. PubMed ID: 35586072 [TBL] [Abstract][Full Text] [Related]
40. A review of the role of chemical modification methods in contemporary mass spectrometry-based proteomics research. Leitner A Anal Chim Acta; 2018 Feb; 1000():2-19. PubMed ID: 29289310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]